781 related articles for article (PubMed ID: 19816503)
1. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
[TBL] [Abstract][Full Text] [Related]
2. Value of morning home blood pressure as a predictor of decline in renal function in patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y
Am J Nephrol; 2008; 28(6):982-9. PubMed ID: 18635925
[TBL] [Abstract][Full Text] [Related]
3. Association of home blood pressure variability with progression of chronic kidney disease.
Okada T; Matsumoto H; Nagaoka Y; Nakao T
Blood Press Monit; 2012 Feb; 17(1):1-7. PubMed ID: 22183043
[TBL] [Abstract][Full Text] [Related]
4. Pulse pressure and progression of chronic kidney disease.
Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
[TBL] [Abstract][Full Text] [Related]
5. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of circadian blood pressure variation in chronic kidney disease.
Agarwal R; Kariyanna SS; Light RP
Am J Nephrol; 2009; 30(6):547-53. PubMed ID: 19844086
[TBL] [Abstract][Full Text] [Related]
7. Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension.
Eto M; Toba K; Akishita M; Kozaki K; Watanabe T; Kim S; Hashimoto M; Ako J; Iijima K; Sudoh N; Yoshizumi M; Ouchi Y
Hypertens Res; 2005 Jan; 28(1):1-7. PubMed ID: 15969248
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
[TBL] [Abstract][Full Text] [Related]
9. The optimal home blood pressure monitoring schedule based on the Didima outcome study.
Stergiou GS; Nasothimiou EG; Kalogeropoulos PG; Pantazis N; Baibas NM
J Hum Hypertens; 2010 Mar; 24(3):158-64. PubMed ID: 19587701
[TBL] [Abstract][Full Text] [Related]
10. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
11. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
[TBL] [Abstract][Full Text] [Related]
14. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
15. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
17. Weekly variation of home and ambulatory blood pressure and relation between arterial stiffness and blood pressure measurements in community-dwelling hypertensives.
Murakami S; Otsuka K; Kubo Y; Shinagawa M; Matsuoka O; Yamanaka T; Nunoda S; Ohkawa S; Kitaura Y
Clin Exp Hypertens; 2005; 27(2-3):231-9. PubMed ID: 15835386
[TBL] [Abstract][Full Text] [Related]
18. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study.
Obara T; Ito K; Ohkubo T; Shibamiya T; Shinki T; Nakashita M; Hara A; Metoki H; Inoue R; Asayama K; Kikuya M; Mano N; Imai Y;
Hypertens Res; 2009 Dec; 32(12):1072-8. PubMed ID: 19779486
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice.
Fagard RH; Van Den Broeke C; De Cort P
J Hum Hypertens; 2005 Oct; 19(10):801-7. PubMed ID: 15959536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
